{"name": "Geneva Biotech",
 "permalink": "geneva-biotech",
 "crunchbase_url": "http://www.crunchbase.com/company/geneva-biotech",
 "homepage_url": "http://www.geneva-biotech.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2012,
 "founded_month": 4,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "biotech-biotechnology-baculovirus",
 "alias_list": null,
 "email_address": "",
 "phone_number": "",
 "description": "Swiss Based Biotech Company",
 "created_at": "Sun Apr 21 12:24:04 UTC 2013",
 "updated_at": "Mon Apr 29 14:54:29 UTC 2013",
 "overview": "\u003Cp\u003EGeneva Biotech is a privately held Biotechnology Company, based in Geneva, Switzerland. Founded in 2012 as a spin-off of the European Molecular Biology Laboratory (EMBL).\u003C/p\u003E\n\n\u003Cp\u003EThe company is developing a portfolio of intelligent protein expression technologies and marketing them across a broad spectrum of application fields.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Daniel",
      "last_name": "Fitzgerald",
      "permalink": "daniel-fitzgerald-2",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}